C. Randal Mills - 27 Apr 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for C. Randal Mills
Issuer symbol
ELUT
Transactions as of
27 Apr 2023
Net transactions value
$0
Form type
4
Filing time
28 Apr 2023, 17:31:00 UTC
Previous filing
23 Jun 2022
Next filing
23 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZYO Class A Common Stock Options Exercise $0 +44,947 +1468% $0.000000 48,008 27 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZYO Restricted Stock Units Award $0 +134,840 $0.000000 134,840 27 Apr 2023 Class A Common Stock 134,840 Direct F2, F3
transaction AZYO Restricted Stock Units Options Exercise $0 -44,947 -33% $0.000000 89,893 27 Apr 2023 Class A Common Stock 44,947 Direct F2, F3
transaction AZYO Restricted Stock Units Award $0 +89,894 $0.000000 89,894 27 Apr 2023 Class A Common Stock 89,894 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,061 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
F3 One-third of the shares underlying these restricted stock units are immediately vested. The remaining two-thirds of the underlying shares vest in four equal annual installments on June 21, 2023, June 21, 2024, June 21, 2025 and June 21, 2026.
F4 The restricted stock units vest in four equal installments upon the Issuer's achievement of a per share price equal to or greater than $12.50, $17.00, $25.00 and $37.00 in each case determined based on twenty consecutive days of trading at or above the applicable threshold subject to the Reporting Person's continuous employment with the Issuer through the vesting date.